FENIMORE ASSET MANAGEMENT INC - NEWLINK GENETICS CORP ownership

NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 128 filers reported holding NEWLINK GENETICS CORP in Q1 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
FENIMORE ASSET MANAGEMENT INC ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q4 2019$31,000
+55.0%
12,3210.0%0.00%0.0%
Q3 2019$20,000
+11.1%
12,3210.0%0.00%0.0%
Q2 2019$18,000
-25.0%
12,3210.0%0.00%0.0%
Q1 2019$24,000
+26.3%
12,3210.0%0.00%0.0%
Q4 2018$19,000
-34.5%
12,3210.0%0.00%0.0%
Q3 2018$29,000
-50.8%
12,3210.0%0.00%
-50.0%
Q2 2018$59,000
-33.7%
12,3210.0%0.00%
-33.3%
Q1 2018$89,000
-11.0%
12,3210.0%0.00%
-25.0%
Q4 2017$100,000
-20.0%
12,3210.0%0.00%
-20.0%
Q3 2017$125,000
+37.4%
12,3210.0%0.01%
+25.0%
Q2 2017$91,000
-69.4%
12,3210.0%0.00%
-69.2%
Q1 2017$297,000
+133.9%
12,3210.0%0.01%
+116.7%
Q4 2016$127,000
-31.4%
12,3210.0%0.01%
-33.3%
Q3 2016$185,000
+33.1%
12,3210.0%0.01%
+28.6%
Q2 2016$139,000
-37.9%
12,3210.0%0.01%
-36.4%
Q1 2016$224,000
-50.0%
12,3210.0%0.01%
-52.2%
Q4 2015$448,000
+1.4%
12,3210.0%0.02%
-4.2%
Q3 2015$442,000
-18.9%
12,3210.0%0.02%
-14.3%
Q2 2015$545,000
-19.1%
12,3210.0%0.03%
-20.0%
Q1 2015$674,000
+37.6%
12,3210.0%0.04%
+40.0%
Q4 2014$490,000
+85.6%
12,3210.0%0.02%
+66.7%
Q3 2014$264,000
-19.3%
12,3210.0%0.02%
-16.7%
Q2 2014$327,000
-6.6%
12,3210.0%0.02%
-5.3%
Q1 2014$350,000
+29.2%
12,3210.0%0.02%
+26.7%
Q4 2013$271,000
+17.3%
12,3210.0%0.02%
+7.1%
Q3 2013$231,000
-4.9%
12,3210.0%0.01%
-12.5%
Q2 2013$243,00012,3210.02%
Other shareholders
NEWLINK GENETICS CORP shareholders Q1 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 93,533$962,0001.69%
WALL STREET ASSOCIATES 108,900$1,119,0000.74%
NORTHWEST WEALTH MANAGEMENT, LLC 57,482$591,0000.60%
Orbimed Advisors 1,991,700$20,475,0000.26%
TFS CAPITAL LLC 92,041$946,0000.25%
Intrinsic Edge Capital Management LLC 40,000$411,0000.18%
SECOR Capital Advisors, LP 100,529$1,033,0000.13%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 176,077$1,810,0000.12%
Piermont Capital Management Inc. 41,400$426,0000.10%
Vident Investment Advisory, LLC 67,209$691,0000.08%
View complete list of NEWLINK GENETICS CORP shareholders